Seo, D. C., and M. R. Torabi. 2007. Reduced admissions for acute myocardial infarction associated with a public smoking ban: Matched controlled study. Journal of Drug Education 37(3):217–226.

Swaminathan, B., and P. Gerner–Smidt. 2007. The epidemiology of human listeriosis. Microbes and Infection 9(10):1236–1243.

Taira, A. V., C. P. Neukermans, and G. D. Sanders. 2004. Evaluating human papillomavirus vaccination programs. Emerging Infectious Diseases 10(11):1915–1923.

Tang, H., D. W. Cowling, J. C. Lloyd, T. Rogers, K. L. Koumjian, C. M. Stevens, and D. G. Bal. 2003. Changes of attitudes and patronage behaviors in response to a smoke-free bar law. American Journal of Public Health 93(4):611–617.

Tong, E. K., and S. A. Glantz. 2007. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Circulation 116(16):1845–1854.

U.S. Surgeon General’s Advisory Committee on Smoking and Health. 1964. Smoking and health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Public Health Service Publication No. 1103 United States. Public Health Service. Office of the Surgeon General.

USDA (U.S. Department of Agriculture)/FSIS (Food Safety and Inspection Service) and EPA (U.S. Environmental Protection Agency). 2012. Microbial risk assessment guideline: Pathogenic organisms with focus on food and water. FSIS Publication No. USDA/ FSIS/2012-001; EPA Publication No. EPA/100/J12/001.

USPSTF (U.S. Preventive Services Task Force). 2008. Grade definitions. (accessed January 2, 2013). (accessed January 3, 2013).

Vasselli, S., P. Papini, D. Gaelone, L. Spizzichino, E. De Campora, R. Gnavi, C. Saitto, N. Binkin, and G. Laurendi. 2008. Reduction incidence of myocardial infarction associated with a national legislative ban on smoking. Minerva Cardioangiologica 56(2):197–203.

WHO (World Health Organization). 2006. Building blocks for tobacco control: A handbook. Geneva: World Health Organization.

———. 2013. Microbiological risks publications. (accessed January 3, 2013).

Woodcock, J. 2010. Memorandum from Janet Woodcock to NDA 021071 (dated September 22, 2010). Re: Decision on continued marketing of rosiglitazone (Avandia, Avandamet, Avandaryl). (accessed January 3, 2013).

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement